SuperworthMovado EPS MOV
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jul 31, 2026
- $1.80
- Latest quarter, Q2 FY27
- $0.53
- +308% on a year earlier
- Fiscal year 2026
- $1.16
- +43% on the year before
Movado's earnings per share was $1.80 over the twelve months to Jul 31, 2026, up 137% on a year earlier.
In its latest quarter, Q2 FY27, it was $0.53, up 308% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $1.16 | +43% |
| FY2025 | $0.81 | −55% |
| FY2024 | $1.82 | −56% |
| FY2023 | $4.12 | +6% |
| FY2022 | $3.88 | n/a |
| FY2021 | −$4.83 | −364% |
| FY2020 | $1.83 | −30% |
| FY2019 | $2.62 | n/a |
| FY2018 | −$0.66 | −144% |
| FY2017 | $1.50 | −21% |
| FY2016 | $1.91 | −6% |
| FY2015 | $2.03 | +3% |
| FY2014 | $1.97 | −12% |
| FY2013 | $2.23 | +76% |
| FY2012 | $1.27 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY27 | $0.53 | +308% | $1.80 | |
| Q1 FY27 | $0.30 | +400% | $1.40 | |
| Q4 FY26 | $0.55 | +53% | $1.16 | |
| Q3 FY26 | $0.42 | +100% | $0.97 | |
| Q2 FY26 | $0.13 | −13% | $0.76 | |
| Q1 FY26 | $0.06 | −33% | $0.78 | |
| Q4 FY25 | $0.36 | −16% | $0.81 | |
| Q3 FY25 | $0.21 | −69% | $0.88 | |
| Q2 FY25 | $0.15 | −48% | $1.34 | |
| Q1 FY25 | $0.09 | −79% | $1.48 | |
| Q4 FY24 | $0.43 | −57% | $1.82 | |
| Q3 FY24 | $0.67 | −48% | $2.39 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Movado's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MOVMovado | $1.80 | +137% a year |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| EYENational Vision | $0.61 | |
| INFUInfuSystem | $0.41 | +78% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| Peer median | $0.79 |
Where Movado ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Movado
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.